Documents tabled in the Senate today raised serious questions about the information provided on PBAC deferrals at Senate Estimates. The advice to Mark Butler indicates the committee's chair may have been indirectly involved in formulating the plan, that the department is legally required to evaluate submissions lodged for March regardless of capacity constraints, and that officials did not consult the industry as directed.
Publication of ministerial advice raises questions about the evidence given at Senate Estimates
November 29, 2024 Latest NewsBioPharmaLatest Video
New Stories
-
Publication of ministerial advice raises questions about the evidence given at Senate Estimates
November 29, 2024 - - Latest News -
We now know what will be considered in March, but not what has been pushed to May
November 29, 2024 - - Latest News -
New data reveals how healthcare professionals can support communities to prepare for COVID-19
November 29, 2024 - - Latest News -
Stakeholders come together for consensus statement in support of 'bridging' fund
November 29, 2024 - - Latest News -
The Dispatched 'Week in Review' Podcast - 29 November
November 28, 2024 - - Podcast -
Senate backs order for the production of documents on submission deferrals
November 27, 2024 - - Latest News -
Outgoing President proposes dramatic expansion in funded access to anti-obesity therapies
November 27, 2024 - - Latest News